Frequently asked questions (FAQ) related to Abbott’s ID NOW rapid molecular test for novel coronavirus (COVID-19).
With the Afinion™ System, there’s no need to send test results to the lab or spend time tracking them down. Find out more ID NOW™ PLATFORM ID NOW™ Platform is a rapid, instrument-based, isothermal system for the qualitative detection of infectious diseases. Find out more ...
The Cholestech LDX™ Analyzer empowers healthcare professionals and patients with a lab-accurate complete lipid profile and glucose in 5 minutes per test cassette. Find out more Service. Support. Answers. Get all the detailed technical support and service you need – the way you need it. We...
Abbott Rapid Diagnostics (formally Alere) and Point of Care Testing (POCT). Find out more about our best-in-class products and solutions.
ID NOW™ Platform Significantly faster than other molecular methods and more accurate than conventional rapid testing, giving you the confidence to make effective patient management decisions sooner. Test first to combat antibiotic resistance The research is as sobering as it is clear: People with in...
- Challenges — Test new habits with week-long Lingo challenges. Earn badges as you complete them and build your healthiest routines. *A study was conducted to assess the biosensor life where 77.1% of biosensors lasted the full 14 days. In other words, when using the product per the package...
The ID NOW COVID-19 assay (Abbott Diagnostics Scarborough, Inc., ME, USA) is a rapid molecular in vitro diagnostic test that employs an isothermal NAAT method for the qualitative detection of SARS-CoV-2 nucleic acid in direct anterior nasal (nasal) or nasopharyngeal swabs from individuals. Th...
Introduced the PLEX-ID Biothreat Assay, which is designed to detect and distinguish 17 different biothreat pathogens. This non-clinical assay enables rapid and accurate detection of potentially dangerous microorganisms that could pose serious threats to human health, food, water and other resources. ...
Panbio and ID NOW continues to be strong with sales this past quarter at a similar amount to the third quarter of last year. Rapid tests were proven to be very important and highly practical tools. They provide a quick and affordable way to test COVID almost anywhere and at any time, wh...
absolute CD4 count are faced with the challenge of not only transporting a patient sample to test sites, but also providing the results back to the patient. Consequently, many patients are lost to follow up.4 The portable analyser provides you with accurate, dependable CD4 results in less than...